Can Fite Biopharma Ltd. Daily Stock Analysis

Daily Stock Analysis, CANF, Can Fite Biopharma Ltd, priceseries

Can Fite Biopharma Ltd. Daily Stock Analysis
Stock Information
Open
1.14
Close
1.11
High
1.16
Low
1.10
Previous Close
1.12
Daily Price Gain
-0.01
YTD High
1.45
YTD High Date
Jan 4, 2022
YTD Low
1.05
YTD Low Date
Jan 27, 2022
YTD Price Change
-0.34
YTD Gain
-23.45%
52 Week High
4.39
52 Week High Date
Mar 16, 2021
52 Week Low
0.94
52 Week Low Date
Dec 7, 2021
52 Week Price Change
-0.71
52 Week Gain
-39.01%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 5. 2018
23.40
Jan 18. 2018
26.41
8 Trading Days
12.87%
Link
LONG
Jan 22. 2018
27.15
Feb 1. 2018
32.11
8 Trading Days
18.26%
Link
LONG
Oct 14. 2019
2.14
Oct 22. 2019
2.32
6 Trading Days
8.29%
Link
LONG
Nov 27. 2019
2.57
Dec 9. 2019
3.53
7 Trading Days
37.37%
Link
LONG
May 15. 2020
1.84
May 27. 2020
1.95
7 Trading Days
5.83%
Link
LONG
Jul 16. 2020
2.03
Jul 30. 2020
2.36
10 Trading Days
16.06%
Link
LONG
Feb 2. 2021
2.20
Feb 3. 2021
2.33
1 Trading Days
5.68%
Link
LONG
Feb 5. 2021
2.09
Feb 18. 2021
2.35
8 Trading Days
12.33%
Link
LONG
Mar 15. 2021
2.04
Mar 23. 2021
2.49
6 Trading Days
22.05%
Link
Company Information
Stock Symbol
CANF
Exchange
NYSE MKT
Company URL
http://http://www.canfite.co.il
Company Phone
-
CEO
N/A
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
-
About

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases, as well as sexual dysfunction.

Description

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases, as well as sexual dysfunction. It offers CF101, which has completed Phase II/III clinical trials for the treatment of psoriasis; completed Phase II clinical trials for the treatment of rheumatoid arthritis; completed Phase I clinical study for the treatment of osteoarthritis; and completed Phase I study for the treatment of uveitis, as well as is in Phase II clinical trials for the treatment of glaucoma or related syndromes of ocular hypertension. The company also develops CF102 that conducts a Phase II study for treating hepatocellular carcinoma and hepatitis C virus; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading